曲美他嗪在顽固性室性早搏治疗中的临床应用

Clinical Application of Trimetazidine in the Treatment of Refractory Premature Ventricular Contractions

目的:观察心肌能量药曲美他嗪辅助治疗顽固性室性早搏的疗效并进行系统评价。方法:治疗组曲美他嗪和胺碘酮与对照组胺碘酮相比较。结果:治疗组治疗后室性早搏发作的次数与对照组显著降低(P<0.01),其症状及24小时动态心电图改善疗效显著优于对照组(P<0.01)。结论:顽固性室性早搏患者使用代谢药物曲美他嗪进行干预是有益的,值得推广。

Objective:To observe the myocardial energy drug trimetasidine in adjuvant treatment of refractory premature ventricular contractions and conduct systematic evaluation of the efficacy.Methods:In the treatment suite of Trimetazidine and amiodarone amiodarone compared with the control group.Results: In the treatment group after treatment with the control the number of premature ventricular contractions onset was significantly lower(P<0.01),its symptoms and to improve the efficacy of 24-hour ambulatory ECG was significantly better than the control group(P<0.01).Conclusion:Metabolism in patients with refractory ventricular premature beats drug trimetazidine intervention is useful and worthy of promotion.